NFKB1 and bacterial infectious disease: To elucidate the potential mechanisms of gcFGF8a induction, we screened inhibitors targeting pathways classically activated by bacterial infection, including Tofacitinib (JAK), LY294002 (PI3K), IWR‐1 (Wnt), SB431542 (TGF‐β), and BAY11‐7082 (NF‐κB).